Mes: agosto 2019

miCure Therapeutics acquired key oligonucleodites patents fron nLife Therapeutics

miCure Therapeutics acquired key oligonucleodites patents fron nLife Therapeutics

miCure Therapeutics is a leading-edge biotech company focused on micro-RNA therapeutics and diagnostics for the central nervous system. Current development program based on mir135 mimic as a therapeutic agent for a long term management of Treatment Resistant Depressive patients (TRD patients). Oligonucleotide delivery solutions developed by nLife Therapeutics reinforces this program by reducing the effective […]